Literature DB >> 23389798

ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China.

Liming Sheng1, Xiaojiang Sun, Lizhen Zhang, Dan Su.   

Abstract

Previous studies found that the ABO blood type alters the individual susceptibility of some malignancies. However, whether such an association exists between ABO blood type and nasopharyngeal carcinoma (NPC) remains unknown. A case-control study was conducted, with 1,538 patients who had NPC and 1,260 cancer-free controls. The association between ABO blood type and NPC incidence was evaluated using unconditional logistic regression analysis. Compared with subjects with blood type O, a relatively higher risk was observed among cases with blood types A or AB, with ORs (95% confidence interval) of 1.287 (1.072 - 1.545), p = 0.007 and 1.390 (1.007 - 1.919), p = 0.045, respectively, after adjusting for gender, age, smoking status and family history of cancer. The rate of distant metastasis was significantly higher among male patients with blood type A than in patients with non-A blood types (6.8 vs. 3.5%, p = 0.027). Our results suggest that blood types A or AB is associated with an increased risk of NPC. Further studies are needed to confirm this association and to explore the mechanisms involved.
Copyright © 2013 UICC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23389798     DOI: 10.1002/ijc.28087

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

Review 1.  Beyond immunohaematology: the role of the ABO blood group in human diseases.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  Clinical characteristics of acute lymphoblastic leukemia in male and female patients: A retrospective analysis of 705 patients.

Authors:  Su-Yi Li; Jie-Yu Ye; Fan-Yi Meng; Chun-Fu Li; M O Yang
Journal:  Oncol Lett       Date:  2015-05-12       Impact factor: 2.967

3.  The role of ABO blood groups in Crohn's disease and in monitoring response to infliximab treatment.

Authors:  Qiao Yu; Lingyun Wang; Shenghong Zhang; Ting Feng; Li Li; Baili Chen; Minhu Chen
Journal:  Blood Transfus       Date:  2016-02-24       Impact factor: 3.443

Review 4.  Hemostasis, cancer, and ABO blood group: the most recent evidence of association.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

5.  ABO Blood Group and the Risk of Esophageal Squamous Cell Carcinoma in Kashmir, a High Risk Region.

Authors:  Malik Tariq Rasool; Ashfaq Hafiz; Saquib Zaffar Banday; Ishtiyaq Ahmad Dar; Shareefa Akhter; Mohd Zubair Qureshi; Sajad Geelani; Nazir Ahmad Dar
Journal:  J Gastrointest Cancer       Date:  2021-06

Review 6.  The prognostic value of ABO blood group in cancer patients.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

7.  The association of ABO blood groups and trauma outcomes: A retrospective analysis of 3779 patients.

Authors:  Michael W Sauder; Timothy W Wolff; Aimee K LaRiccia; M Chance Spalding; Urmil B Pandya
Journal:  Int J Crit Illn Inj Sci       Date:  2021-06-29

8.  Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer.

Authors:  Wei Wang; Lei Liu; Zhiwei Wang; Min Wei; Qi He; Tianlong Ling; Ziang Cao; Yixin Zhang; Qiang Wang; Minxin Shi
Journal:  BMC Surg       Date:  2015-09-29       Impact factor: 2.102

9.  Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer.

Authors:  Wenna Zhang; Yupei Chen; Guanqun Zhou; Xu Liu; Lei Chen; Linglong Tang; Yanping Mao; Ying Sun; Jun Ma
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

10.  Incidence and metastasis of cutaneous malignant melanoma with respect to ABO blood groups: a case-controlled study in northeast of China.

Authors:  Liang Chang; Junrui Pei; Chenlong Li; Ping Zhang; Dan Zhou; Wenzhong Du; Xing Liu; Chuanlu Jiang
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.